Clinical and experimental study on gastric mucosal pathology, gene expression, cAMP and trace elements of pixu patients

Table 3 Quantitative changes of cAMP, DNA, Zn, Cu, ZnO and CuO levels in gastric mucosa from the various intestinal metaplasia groups

Intestinal metaplasia	cAMP	DNA	Zn	ZnO	Cu	CuO
1 Non-intestinal metaplasia	15.63 ± 1.06 (n = 15)	10.95 ± 1.32 (n = 9)	3.27 ± 0.61 (n = 14)	1.62 ± 0.64 (n = 14)	4.66 ± 0.62 (n = 14)	2.67 ± 0.53 (n = 14)
2 Small intestinal metaplasia	9.55 ± 1.62 (n = 20)	15.62 ± 5.04 (n = 13)	2.44 ± 0.44 (n = 11)	0.71 ± 0.10 (n = 11)	3.51 ± 0.66 (n = 11)	1.62 ± 0.32 (n = 11)
P value	< 0.001	< 0.01	< 0.001	< 0.001	< 0.01	< 0.001
3 Colonic intestinal metaplasia	4.35 ± 0.93 (n = 22)	29.99 ± 12.41 (n = 17)	1.51 ± 0.51 (n = 16)	0.31 ± 0.09 (n = 16)	2.48 ± 0.68 (n = 16)	1.07 ± 0.09 (n = 16)
NO 1:3 P	< 0.001	< 0.001	< 0.001	< 0.001	< 0.01	< 0.001
NO 2:3 P	< 0.001	< 0.00	< 0.001	< 0.0	< 0.001	< 0.001